Abstract
Tayek and Umpierrez ask 2 questions. The first is whether the importance of relative hyperglycemia, as measured by the glycemic gap ( 1), depends on the presence of diabetes prehospital admission. They note as previously observed by others, hyperglycemia during illness in those without established diabetes, or “stress hyperglycemia (SH),” was found to be associated with up to a 5-fold higher mortality rate than in those presenting with the same degree of hyperglycemia in the setting of previously established diabetes ( 2-4). The authors’ second question is whether the observation of increased mortality in SH reflects new- or recent-onset diabetes, whereby hyperglycemia occurring either shortly before or at the onset of illness may be promoting worse outcomes. The lack of detailed blood glucose measurements from 3 months prior to hospitalization has led to conflicting findings in the literature ( 5). While we do not have these data due to the retrospective nature of the study, our population is unique in that each individual (N = 1786) had a recent glycated hemoglobin A1c available either from the ambulatory setting in the last 3 months or obtained at admission. Our cohort included individuals with preexisting diabetes (91.4% of cohort), defined as having a diabetes diagnosis on their problem list (82.0%) or A1c greater than 6.4% (9.5%), suggesting that the majority were not newly dysglycemic on admission. Importantly, while SH (glucose >180 mg/dL twice within 24 hours at any time during admission) did not drive our results given the low prevalence (8.6%), all SH patients would have a high glycemic gap by definition. Hence, our results overall support the existing SH literature but also identify higher risk in those with preexisting diabetes presenting with greater degrees of acute glycemic dysregulation.

This publication has 5 references indexed in Scilit: